These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Robak T; Błasińska-Morawiec M; Krykowski E; Hansz J; Komarnicki M; Kazimierczak M; Konopka L; Maj S; Hellmann A; Zaucha JM; Urasiński L; Zdziarska B; Kotlarek-Haus S; Usnarska-Zubkiewicz L; Kuratowska Z; Dwilewicz-Trojaczek J; Hołowiecki J; Krawczyk-Kulis M; Grieb P Leuk Lymphoma; 1996 Jun; 22(1-2):107-11. PubMed ID: 8724536 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Hoffman MA; Janson D; Rose E; Rai KR J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556 [TBL] [Abstract][Full Text] [Related]
10. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial. Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277 [TBL] [Abstract][Full Text] [Related]
11. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Chadha P; Rademaker AW; Mendiratta P; Kim B; Evanchuk DM; Hakimian D; Peterson LC; Tallman MS Blood; 2005 Jul; 106(1):241-6. PubMed ID: 15761021 [TBL] [Abstract][Full Text] [Related]
14. Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia. Damasio EE; Resegotti L; Masoudi B; Bruni R; Cerri R; Isaza A; Clavio M; Risso M; Rossi E; Spriano M; Truini M Recenti Prog Med; 1998 Feb; 89(2):68-73. PubMed ID: 9558908 [TBL] [Abstract][Full Text] [Related]
15. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia]. Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801 [TBL] [Abstract][Full Text] [Related]
16. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group. Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268 [TBL] [Abstract][Full Text] [Related]